NicAzel

Manufacturer
Elorac, Inc
Effective date
2021-12-08
Label type
DIETARY SUPPLEMENT
Version
20
Source
full-release
Hydrated at
2026-06-01 02:50:15

Label at a glance#

ProductNicAzel
Active ingredientNIACINAMIDE, ZINC, AZELAIC ACID, PYRIDOXINE, COPPER, FOLIC ACID
Label structure12 sections

Label contents#

Full prescribing information#

NicAzel​® (nicotinamide, zinc, azelaic acid, pyridoxine, copper, folic acid)

STATEMENT OF IDENTITY SECTION

Prescription Only

Dietary Supplement

DESCRIPTION

STATEMENT OF IDENTITY SECTION

Nicazel Tablets is a dietary supplement for oral administration. Each tablet is purple-colored, oval-shaped, and debossed with "EL501" on one side.

Ingredients:

STATEMENT OF IDENTITY SECTION

Each oral tablet provides:

Nicotinamide (Vitamin B3).............600 mg
Zinc (Zinc Oxide)...........................10 mg
Azelaic Acid....................................5 mg
Pyridoxine (Vitamin B6)...................5 mg
Copper (Cupric Oxide)..................1.5 mg
Folic Acid....................................500 mcg

Other Ingredients:

STATEMENT OF IDENTITY SECTION

Microcrystalline cellulose, stearic acid, purple coating (polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, FD&C Blue no. 2, FD&C Red no. 40), silicon dioxide, magnesium stearate.

HEALTH CLAIM SECTION

Nicotinamide is a water-soluble component of the vitamin B complex group. In vivo, nicotinamide is incorporated into nicotinamide adenine dinucleotide (NAD), and nicotinamide adenine dinucleotide phosphate (NADP). NAD and NADP function as coenzymes in a wide variety of enzymatic oxidation-reduction reactions essential for tissue respiration, lipid metabolism, and glycogenolysis.

Nicotinamide has demonstrated anti-inflammatory actions that may be of benefit in patients with acne including, but not limited to, suppression of antigen-induced lymphocytic transformation and inhibition of 3',5'- cyclic AMP phosphodiesterase. Nicotinamide has been demonstrated to block the inflammatory actions of iodides known to precipitate or exacerbate acne.

Nicotinamide lacks the vasodilator, gastrointestinal, hepatic and hypolipemic actions of nicotinic acid or niacin. As such, nicotinamide has not been shown to produce the flushing, itching and burning sensations of the skin, as is commonly seen when large doses of nicotinic acid or niacin are administered orally.

Zinc has been shown to inhibit the inflammatory polymorphonuclear leukocyte chemotaxis in acne patients. Zinc has also demonstrated an inhibitory effect on the lipase of the three Propionibacterium species found in human pilosebaceous follicles. Patients with acne have been shown to have significantly lower serum zinc levels than matched healthy controls.

Azelaic Acid is a dietary constituent (e.g., in whole grain cereals and animal products) that has been shown to possess antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis. The antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis. A normalization of keratinization leading to an anticomedonal effect of azelaic acid may be also contributed to its topical use for treatment of acne vulgaris.

Copper is an essential trace mineral in human nutrition. Although rare, copper deficiency has been induced by supplemental zinc therapy.

Folic acid serves as an essential cofactor of the biosynthesis of thymidine and purine nucleotides required for normal cellular DNA synthesis. Deficiencies of folic acid have been demonstrated to occur in some cutaneous disorders.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

USE

HEALTH CLAIM SECTION

As a dietary supplement for inflammatory skin disorders, such as acne vulgaris or rosacea, and/or individuals who are deficient in or at risk of deficiency in one or more of the components in Nicazel Tablets.

WARNINGS

WARNINGS SECTION

As with any dietary supplement, if you are pregnant, nursing or taking medication, consult your doctor before use. Nicazel Tablets is not formulated for use in children under 6 years of age.

Folic Acid is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

PRECAUTIONS

PRECAUTIONS SECTION

Allergic sensitization has been reported rarely following oral administration of folic acid.

Folic acid above 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.

DOSAGE & ADMINISTRATION 

DOSAGE & ADMINISTRATION SECTION

Usual Adult dose is one or two tablets taken once or twice a day with or without food or as prescribed by a physician.

HOW SUPPLIED

DOSAGE & ADMINISTRATION SECTION

60 tablets NDC 42783-501-60

Store between 15°-30°C (59°-86°F).

DOSAGE & ADMINISTRATION SECTION

Manufactured for
Elorac, Inc.
100 Fairway Drive, Ste. 134
Vernon Hills, IL 60061
Made in the USA

U.S. Patent Pending

02/2015
©2015 Elorac, Inc.
141609-3

Dosage:

DOSAGE & ADMINISTRATION SECTION

Adults - One or two tablets taken once or twice a day with or without food or as prescribed by a physician.
Store between 15o-30oC (59o-86oF).

Purple-colored, oval-shaped tablets debossed "EL501" on one side.

PLEASE REFER TO PACKAGE FOLDOUT FOR WARNINGS AND PRECAUTIONS.

Keep out of reach of children.

DOSAGE & ADMINISTRATION SECTION

Manufactured for:
Elorac, Inc.
Vernon Hills, IL 60061

Rev. 02/15
7164-2

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

42783-501-60

NicAzel®
(nicotinamide, zinc, azelaic acid,  pyridoxine, copper, folic acid)

Dietary Supplement

Prescription Only
60 Tablets

label-nicazel.jpglabel-nicazel.jpg

label-nicazel.jpglabel-nicazel.jpg

fold-out-nicazel.jpgfold-out-nicazel.jpg

fold-out-nicazel.jpgfold-out-nicazel.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1145114azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [NicAzel]SBD20
1145110azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral TabletSCD20
1145110azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vit-B6 5 MG / ZNO 10 MG Oral TabletSY20
1145114azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vit-B6 5 MG / ZNO 10 MG Oral Tablet [NicAzel]SY20
1145110azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vitamin B6 5 MG / ZNO 10 MG Oral TabletSY20
1145114azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vitamin B6 5 MG / ZNO 10 MG Oral Tablet [NicAzel]SY20
1145114NicAzel (azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / vitamin B3 600 MG / vitamin B6 5 MG / zinc oxide 10 MG) Oral TabletSY20

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
AZELAIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
COPPER Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
PYRIDOXINE Pharmacologic Class Indexing1Indexing - Pharmacologic Class20170310

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c599c4a0-705d-4ebb-ab1f-977af038f96aProduct name120251124
59361619-24d9-b610-eca6-5a7f25ed5e03Product name520240909
91c62db0-0295-c81c-d10a-0856c259edd6Product name220200428
6c6fc281-9445-2e9e-1c29-a09ddbc4299cProduct name220200213
d32bc2b8-0bb7-2216-87aa-24639646e202Product name320190619
5e18e798-5614-cf5c-0185-38b1cb77a093Product name220160822
2a856070-cbe7-4f85-be0f-09885ff91196Product name120150806

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42783-501-60NicAzel60 in 1 BOTTLETABLET, COATED6020

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42783-501NICAZEL (NICOTINAMIDE, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET, COATED [ELORAC, INC]201 package rows20211209_fc729ca5-3846-48fd-8d8c-d2b6a7563741.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42783-501-60EA - Each42783-501312fc95a-cd2a-4773-be17-bce5e37bd3ef12014-09-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AZELAIC ACIDACTIVE INGREDIENTF2VW3D43YT10
COPPERACTIVE INGREDIENT789U1901C510
FOLIC ACIDACTIVE INGREDIENT935E97BOY810
NIACINAMIDEACTIVE INGREDIENT25X51I8RD410
PYRIDOXINEACTIVE INGREDIENTKV2JZ1BI6Z10
ZINCACTIVE INGREDIENTJ41CSQ7QDS10
AZELAIC ACIDACTIVE MOIETYF2VW3D43YT10
COPPERACTIVE MOIETY789U1901C510
FOLIC ACIDACTIVE MOIETY935E97BOY810
NIACINAMIDEACTIVE MOIETY25X51I8RD410
PYRIDOXINEACTIVE MOIETYKV2JZ1BI6Z10
ZINCACTIVE MOIETYJ41CSQ7QDS10
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U10
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQK10
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOA10
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I3010
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A10
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J99010
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU410
TALCINACTIVE INGREDIENT7SEV7J4R1U10
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP10

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42783-50142783-501-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 247 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER / ORAL2 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
POLYVINYL ALCOHOLPOLYVINYL ALCOHOL532B59J990SOLUTION/ DROPS / OPHTHALMIC1.4 %w/vExact identifier — unii candidate
17 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER / TOPICAL9235 mgExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPLOTION / TOPICALNAExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION / ORAL1600 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, COATED / ORAL184 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION, EXTENDED RELEASE / ORAL46 mgExact identifier — unii candidate
35 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOADROPS / ORALNAExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION / ORAL400 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4DROPS / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED PELLETS / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE PARTICLES / ORAL56 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UDROPS / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOASOLUTION / DENTALNAExact identifier — unii candidate
28 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED, EXTENDED RELEASE / ORAL20 mgExact identifier — unii candidate
35 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKCAPSULE / ORAL4 mgExact identifier — unii candidate
11 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER / ORAL602 mgExact identifier — unii candidate
49 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET, FILM COATED / ORAL2 mgExact identifier — unii candidate
11 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER, FOR SUSPENSION / ORAL297 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, EXTENDED RELEASE / ORAL450 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY / VAGINALNAExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOATABLET, CHEWABLE / ORAL40 mgExact identifier — unii candidate
28 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOAELIXIR / ORAL12.5 mg/5mlExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGEL / TOPICAL0.06 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, FOR SUSPENSION / ORAL296 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, DELAYED RELEASE PARTICLES / ORAL170 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
49 equally ranked IID candidates
POLYVINYL ALCOHOLPOLYVINYL ALCOHOL532B59J990SUSPENSION / OPHTHALMIC1.4 %w/wExact identifier — unii candidate
17 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL357 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
35 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, FOR SUSPENSION / ORAL278 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / SUBLINGUAL43.2 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, DELAYED RELEASE / ORAL366 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED / ORAL36 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION, EXTENDED RELEASE / ORAL70 mgExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1ULOZENGE / ORAL50 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, EXTENDED RELEASE / ORAL90 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET, EXTENDED RELEASE / ORAL2.78 mgExact identifier — unii candidate
11 equally ranked IID candidates
POLYVINYL ALCOHOLPOLYVINYL ALCOHOL532B59J990CREAM / VAGINAL0.5 %w/wExact identifier — unii candidate
17 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOASUSPENSION/ DROPS / ORAL1 mgExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPFILM / BUCCAL3 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / SUBLINGUAL10 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UIMPLANT / INTRAVITREAL1.66 mgExact identifier — unii candidate
28 equally ranked IID candidates
TALCTALC7SEV7J4R1UOINTMENT / TOPICAL74.6 %w/wExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION, EXTENDED RELEASE / ORAL1120 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SOLUTION / ORAL690 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, EXTENDED RELEASE / ORAL117 mgExact identifier — unii candidate
39 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4 IN LOOK Ginseng Anit wrink Anti wrinkle essenceNIACINAMIDEGuangzhou Yanhou Cosmetics Co., Ltd.3b1c9d30-ebaa-217d-e063-6294a90a1ca72025-07-29WarningsName fallback
generic name: NIACINAMIDE
TURMERICFaceCreamNIACINAMIDEShengnan (Guangzhou) Cosmetics Co., LTD2b0652be-a216-d66b-e063-6394a90a0b282025-01-06WarningsName fallback
generic name: NIACINAMIDE
Dr.Jucre Rebirth EyeNIACINAMIDENATURECELL CO., LTD.2ab43971-57b4-aa2c-e063-6294a90a8f7b2025-01-02WarningsName fallback
generic name: NIACINAMIDE
Dr.Jucre Rebirth BoosterNIACINAMIDENATURECELL CO., LTD.2ab42408-1323-9d79-e063-6394a90a434b2025-01-02WarningsName fallback
generic name: NIACINAMIDE
Dr.Jucre RebirthNIACINAMIDENATURECELL CO., LTD.2ab4562d-e8b4-c9a4-e063-6394a90ada472025-01-02WarningsName fallback
generic name: NIACINAMIDE
Pugan vegan White Tomato formula Cleansing GelNIACINAMIDELAON COMMERCE co ltd0fbc61a2-88ef-08db-e063-6394a90a5b1e2024-01-24WarningsName fallback
generic name: NIACINAMIDE
DERLADIE LABORATOIRE PORE TIGHTENING AMPOULENIACINAMIDELAON COMMERCE co ltd0be5f72e-f80e-6cfa-e063-6394a90a3fc32023-12-07WarningsName fallback
generic name: NIACINAMIDE
DERLADIE HerbalExtract BodySolution MISTNIACINAMIDELAON COMMERCE co ltd0185e1ff-22a6-2daa-e063-6394a90a5d362023-07-28WarningsName fallback
generic name: NIACINAMIDE
THE SKINHOUSE ALOE SOOTHING VITAMINNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.516f3790-a127-455c-9eae-d41895fe24112021-07-14WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital BrightEmulsionNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a2c19f6e-80d2-8178-e053-2995a90a1a892020-04-08WarningsName fallback
generic name: NIACINAMIDE
SFERANGS VITA C CAPSULEBOOSTERNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a22c67a6-1841-2419-e053-2995a90a91922020-03-31WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital BrightCreamNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a21cbf42-482c-2d95-e053-2a95a90a1a482020-03-30WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital Bright EmulsionNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a21d0eba-a96c-72e8-e053-2995a90addfb2020-03-30WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital Bright EyeCreamNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a21d3c87-0a7f-2e15-e053-2a95a90aee692020-03-30WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital BrightSerumNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a21d8184-258f-679e-e053-2995a90ad7c42020-03-30WarningsName fallback
generic name: NIACINAMIDE
THE SKIN HOUSE Vital Bright TonerNIACINAMIDENOKSIBCHO cosmetic Co., Ltd.a21daae8-98d6-203a-e053-2a95a90aafe52020-03-30WarningsName fallback
generic name: NIACINAMIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.